PRGOPERRIGO Co plc

NYSE perrigo.com


$ 33.10 $ 0.05 (0.15 %)    

Thursday, 02-May-2024 15:18:04 EDT
QQQ $ 426.98 $ 1.74 (0.41 %)
DIA $ 382.50 $ 0.98 (0.26 %)
SPY $ 505.08 $ 0.68 (0.13 %)
TLT $ 88.86 $ 0.64 (0.73 %)
GLD $ 213.32 $ 0.85 (0.4 %)
$ 32.9
$ 33.05
$ 0.00 x 0
$ 36.00 x 400
$ 32.78 - $ 33.35
$ 25.52 - $ 39.22
2,413,977
na
4.43B
$ 0.70
nm
TBD
na
na ($ 0.03)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 02-27-2024 12-31-2023 10-K
2 11-07-2023 09-30-2023 10-Q
3 08-08-2023 07-01-2023 10-Q
4 05-09-2023 04-01-2023 10-Q
5 02-28-2023 12-31-2022 10-K
6 11-08-2022 10-01-2022 10-Q
7 08-09-2022 07-02-2022 10-Q
8 05-11-2022 04-02-2022 10-Q
9 03-01-2022 12-31-2021 10-K
10 11-12-2021 10-02-2021 10-Q
11 08-11-2021 07-03-2021 10-Q
12 05-12-2021 04-03-2021 10-Q
13 03-01-2021 12-31-2020 10-K
14 11-05-2020 09-26-2020 10-Q
15 08-05-2020 06-27-2020 10-Q
16 05-05-2020 03-28-2020 10-Q
17 02-27-2020 12-31-2019 10-K
18 11-06-2019 09-28-2019 10-Q
19 08-08-2019 06-29-2019 10-Q
20 05-09-2019 03-30-2019 10-Q
21 02-27-2019 12-31-2018 10-K
22 11-08-2018 09-29-2018 10-Q
23 08-09-2018 06-30-2018 10-Q
24 05-08-2018 03-31-2018 10-Q
25 03-01-2018 12-31-2017 10-K
26 11-09-2017 09-30-2017 10-Q
27 08-10-2017 07-01-2017 10-Q
28 05-30-2017 04-01-2017 10-Q
29 05-22-2017 12-31-2016 10-K
30 11-10-2016 10-01-2016 10-Q
31 08-10-2016 07-02-2016 10-Q
32 05-16-2016 04-02-2016 10-Q
33 11-02-2015 09-26-2015 10-Q
34 08-13-2015 06-27-2015 10-K
35 04-29-2015 03-28-2015 10-Q
36 02-05-2015 12-27-2014 10-Q
37 11-06-2014 09-27-2014 10-Q
38 08-14-2014 06-28-2014 10-K
39 05-07-2014 03-29-2014 10-Q
40 02-06-2014 12-28-2013 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 perrigo-secures-binding-offer-to-divest-its-hra-pharma-rare-diseases-business-for-up-to-275m

The total consideration of up to €275 million, consisting of an upfront cash payment of €190 million and up to €85 million in p...

 canaccord-genuity-maintains-buy-on-perrigo-maintains-42-price-target

Canaccord Genuity analyst Susan Anderson maintains Perrigo (NYSE:PRGO) with a Buy and maintains $42 price target.

 disney-to-rally-around-10-here-are-10-top-analyst-forecasts-for-monday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including...

 piper-sandler-maintains-overweight-on-perrigo-raises-price-target-to-39

Piper Sandler analyst Korinne Wolfmeyer maintains Perrigo (NYSE:PRGO) with a Overweight and raises the price target from $35...

 cvs-healths-zero-cost-coverage-paves-way-for-otc-birth-control-access

CVS Health expands coverage to include the first OTC birth control pill in the U.S., offering accessible contraception without ...

Core News & Articles

-Bloomberg

Core News & Articles

https://www.washingtonpost.com/politics/2024/03/26/abortion-pill-supreme-court-arguments-mifepristone/The Supreme Court on Tues...

 perrigo-commences-shipments-of-opill-to-retailers-nationwide

Opill®, the first ever daily birth control pill available without a prescription in the United States, will be available in-sto...

 around-2m-bet-on-tile-shop-holdings-check-out-these-4-stocks-insiders-are-buying

Although U.S. stocks closed higher on Thursday, there were a few notable insider trades.

 perrigo-form4-filing-shows-ceo-taylor-patrick-lockwood-purchased-9500-shares-at-an-average-price-of-2654-per-share

- SEC Filing

 jp-morgan-maintains-overweight-on-perrigo-lowers-price-target-to-41

JP Morgan analyst Chris Schott maintains Perrigo (NYSE:PRGO) with a Overweight and lowers the price target from $48 to $41.

 otc-medicine-player-perrigo-outlines-three-year-cost-saving-plan-posts-mixed-q4-earnings

Perrigo Q4 2023 net sales reach $1.2 billion, up 0.1% YoY. Explore Project Energize for long-term growth.

 why-helix-energy-solutions-shares-are-trading-lower-by-11-here-are-other-stocks-moving-in-tuesdays-mid-day-session

Shares of Helix Energy Solutions Group, Inc. (NYSE: HLX) fell sharply during Tuesday’s session following weak earnings.

 perrigo-will-launch-project-energize-investment-and-efficiency-program-in-q1-2024-to-drive-its-one-perrigo-sustainable-value-accretive-growth-strategy--restructuring-is-expected-to-impact-approximately-6-of-perrigo-roles

Project Energize will be initiated in Q1 2024, subject to local law and consultation requirements, and is expected to deliver a...

 perrigo-q4-adjusted-eps-086-beats-083-estimate-sales-116b-miss-118b-estimate

Perrigo (NYSE:PRGO) reported quarterly earnings of $0.86 per share which beat the analyst consensus estimate of $0.83 by 3.61 p...

 earnings-scheduled-for-february-27-2024

Companies Reporting Before The Bell • Gaotu Techedu (NYSE:GOTU) is expected to report quarterly loss at $0.07 per share on rev...

 perrigo-increases-its-quarterly-dividend-1-from-0273-to-0276-per-share

The cash dividend is payable on March 26, 2024, to shareholders of record on March 8, 2024.

Core News & Articles

- Reuters

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION